CUL4A, ERCC5, and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study
CUL4A、ERCC5 和 ERCC1 作为曲贝替定治疗晚期软组织肉瘤 (STS) 疗效的预测因子：西班牙肉瘤研究组 (GEIS) 的研究
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers12051128
Moura, David S; Sanchez-Bustos, Paloma; Fernandez-Serra, Antonio; Lopez-Alvarez, María; Mondaza-Hernandez, José L; Blanco-Alcaina, Elena; Gavilan-Naranjo, Angela; Martinez-Delgado, Paula; Lacerenza, Serena; Santos-Fernandez, Paloma; Carrasco-Garcia, Irene; Hidalgo-Rios, Samuel; Gutierrez, Antonio; Ramos, Rafael; Hindi, Nadia; Taron, Miguel; Lopez-Guerrero, Jose Antonio; Martin-Broto, Javier
